If a treatment is shown to increase human lifespan in a randomized controlled trial by 2030, what was the treatment?

255Ṁ276

2030

ALL

1.8%

Metformin

22%

Calorie restriction

10%

Rapamycin

67%

Other

Resolves according to the intervention in the study that causes this market to resolve YES, if it resolves YES, and N/A otherwise.

Longevity

Get

1,000

to start trading!

People are also trading

Will we have a treatment for Alzheimer's disease that halts the progression of the disease by 2035?

21% chance

By 2050, will there be a cure to aging?

39% chance

Will a scientific discovery extend human lifespan by more than 10 years within the next 20 years?

35% chance

By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?

Will any company successfully develop a therapeutic treatment that rejuvenates healthspan by at least 10 years by 2030?

39% chance

ITP: Which drug(s) will increase median lifespan the most in males by 2030?

By 2030, will there be a cure to aging?

11% chance

What will be the next compound produced and tested by the ITP that will be shown to have a statistically significant effect on both median and 90th percentile lifespan?

When will at least 5% of the world population be undergoing treatments expected to extend their lives at least 10 years?

Will NR or NMN supplementation by proven to promote longevity-related outcomes in healthy adults by 2025?

Sort by:

How exactly will 'calorie restriction' resolve- I think 'eating less calories' would measurably increase lifespan if the whole US population did it, because a lot of it is obese?

10k no limit on rapamycin 1 day only

How much an improvement do you need? E.g. would statins qualify if they weren't already known?

@MartinModrak Alyssa Vance says on the other market that this one is conditioned on:
> Any effect size counts, as long as the trial clearly shows that it actually exists. (In practice, very small effect sizes would be impossible to show in this way, because the sample size goes as the inverse square of the effect size. So a treatment which extended life one week would be impossible to prove, because you'd need zillions of people.)

If statins already have such a trial, that would be interesting; seems that it would count as a YES resolution for that market and a Statins resolution for this market, though I'm following Alyssa's resolution there.